CardiaTec, a company building a heart tissue multi-nomics dataset, has raised $6.5M
CardiaTec, a company using computational methods to study cardiovascular disease, has raised $6.5 million in seed funding to build the world's first proprietary human heart tissue multi-omics dataset and advance its drug development pipeline.